3-(3-FLUORO-4-(6-(5-METHYL-1,3,4-OXADIAZOL-2-YL)PYRIDIN-3-YL)PHENYL)-5-(HYDROXYMETHYL)-1,3-OXAZOLIDIN-2-ONE, (5R)-
UNII YE64X2S6XG
Substance Identification & Data
This profile provides standardized clinical and technical data for 3-(3-fluoro-4-(6-(5-methyl-1,3,4-oxadiazol-2-yl)pyridin-3-yl)phenyl)-5-(hydroxymethyl)-1,3-oxazolidin-2-one, (5r)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) YE64X2S6XG.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 856866-79-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C18H15FN4O4 MTFKOJLUBNPXOJ-CYBMUJFWSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 3-(3-fluoro-4-(6-(5-methyl-1,3,4-oxadiazol-2-yl)pyridin-3-yl)phenyl)-5-(hydroxymethyl)-1,3-oxazolidin-2-one, (5r)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.